Impax to Present at the Cowen and Company 29th Annual Health Care Conference March 18

March 12, 2009

HAYWARD, Calif.--(BUSINESS WIRE)--Mar. 12, 2009-- Impax Laboratories, Inc. (OTCBB: IPXL.OB) today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will present at the Cowen and Company 29th Annual Health Care Conference on Wednesday, March 18th, at 8:00 a.m. Eastern time. The conference will be held at The Boston Marriott Copley Place in Boston.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company’s web site at This presentation will be archived on the Company’s web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at:

Source: Impax Laboratories, Inc.

Impax Laboratories, Inc.
Mark Donohue, Sr. Director Investor Relations
(215) 933-3526